Current News in Medicine

Saturday, May 16, 2015

FDA targets SGLT2 inhibitors canagliflozin, dapagliflozin, and empagliflozin.

Amy Dugan: In 2003 I earned my PhD in Molecular Cellular Physiology from the University of Cincinnati. My research focus for 12 years was on the immune response to infection and wound healing in response to stress in a mouse model. Overall I have over 10 years of teaching experience. I have taught undergraduate students anatomy and physiology, and microbiology, both lecture and lab. I have taught pathophysiology as well. Classes that I have taught online include anatomy and physiology and pathophysiology. I have some graduate level teaching experience including the following: human physiology, human gross anatomy, and neurophysiology. I love spending time with my family that includes my hubby, 2 sons in their 20s, and my 6 year old granddaughter. I enjoy nature. My hobbies include, reading, hiking, swimming, lifting weights and eating

Powered by Blogger.